Ravi Kant Gupta
Overview
Explore the profile of Ravi Kant Gupta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pratap B, Gupta R, Bhardwaj B, Nag M
Jpn Dent Sci Rev
. 2019 Nov;
55(1):126-138.
PMID: 31687052
This review article compiles the characteristics of resin based dental composites and an effort is made to point out their future perspectives. Recent research studies along with few earlier articles...
2.
Pratap B, Gupta R, Bhardwaj B, Nag M
J Mech Behav Biomed Mater
. 2019 Jul;
99:86-92.
PMID: 31349148
This paper investigates the effect of %wt composition of BisGMA/TEGDMA, stirring time, bench time, curing time and filler loading on polymerization shrinkage and micro-hardness of resin based dental composites. The...
3.
Negandhi P, Neogi S, Das A, Chopra S, Phogat A, Sahota R, et al.
WHO South East Asia J Public Health
. 2018 Aug;
7(2):114-121.
PMID: 30136670
Background: Each year, 2.6 million babies are stillborn worldwide, almost all in low- and middle-income countries. Several global initiatives, including the Sustainable Development Goals and the Every Newborn Action Plan,...
4.
Sahoo M, Tripathi M, Deepak R, Gupta R, Damle N, Bal C
Indian J Nucl Med
. 2016 Apr;
31(2):162-4.
PMID: 27095874
No abstract available.
5.
Gupta R, Tripathi M, Sahoo M, Nazar A, Agarwal K, Kumar K, et al.
Indian J Nucl Med
. 2016 Feb;
31(1):83-4.
PMID: 26917909
The present case highlights the importance of history taking in solving the dilemmas of variant F-18 FDG uptake on PET/CT. Asymmetrically increased, abnormal looking, FDG uptake in the right breast...
6.
Neogi S, Negandhi P, Gupta R, Ganguli A, Zodpey S, Singh A, et al.
Drug Saf
. 2015 Oct;
39(1):91-2.
PMID: 26507884
No abstract available.
7.
Neogi S, Negandhi P, Chopra S, Mukherjee Das A, Zodpey S, Gupta R, et al.
Paediatr Perinat Epidemiol
. 2015 Oct;
30(1):56-66.
PMID: 26444206
Background: Stillbirth is a prevalent adverse outcome of pregnancy in India despite efforts to improve care of women during pregnancy. Risk factors for stillbirths include sociodemographic factors, medical complications during...
8.
Neogi S, Negandhi P, Ganguli A, Chopra S, Sandhu N, Gupta R, et al.
BMC Pregnancy Childbirth
. 2015 Sep;
15:208.
PMID: 26341639
Background: Sex ratio is an important indicator of development. Despite all the measures undertaken for improvement, it remains an issue of concern in India, with Haryana having a very low...
9.
Neogi S, Negandhi P, Sandhu N, Gupta R, Ganguli A, Zodpey S, et al.
Drug Saf
. 2015 Jun;
38(9):789-97.
PMID: 26091849
Introduction: Congenital malformations (CMFs) are a major public health problem in India. Consanguineous marriages, infections during pregnancy, folic acid deficiency during the periconceptional period, exposure to pesticides and a history...
10.
Kumar K, Singh H, Gupta R, Bal C, Kumar R
Clin Nucl Med
. 2014 Oct;
40(4):e251-2.
PMID: 25275420
Erlotinib is a reversible epidermal growth factor receptor tyrosine kinase inhibitor used to treat advanced non-small cell lung carcinoma patients who have shown progression on at least 1 prior chemotherapy...